Small Study: FDA-Approved Weight Loss Drugs Safe in People With Multiple Sclerosis
August 14, 2024
August 14, 2024
NEW YORK, Aug. 14 (TNSres) -- The National Multiple Sclerosis Society issued the following news:
A small study of medical records in people with MS taking GLP-1 receptor agonist drugs showed the treatments were safe and well-tolerated. Weight loss was observed but did not occur as quickly as people without MS in other studies.
Background: In MS, obesity has been linked to worsened symptoms, higher disease severity, and poorer outcome, which highlights the importance of . . .
A small study of medical records in people with MS taking GLP-1 receptor agonist drugs showed the treatments were safe and well-tolerated. Weight loss was observed but did not occur as quickly as people without MS in other studies.
Background: In MS, obesity has been linked to worsened symptoms, higher disease severity, and poorer outcome, which highlights the importance of . . .